Titre:
  • INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes.
Auteur:Dunger, David B; Bruggraber, SFA; Mander, AP; Marcovecchio, ML; Tree, T; Chmura, PJ; Knip, M; Schulte, AM; Mathieu, C; Cnop, Miriam; And other members of, INNODIA consortium
Informations sur la publication:Trials, 23, 1, page (414)
Statut de publication:Publié, 2022-05-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Beta-cell function
C-peptide
Master protocol
Phase 2
Prevention
Trials
Type 1 diabetes
MeSH keywords:Adolescent
Adult
Biomarkers
COVID-19
Child
Diabetes Mellitus, Type 1 -- diagnosis -- drug therapy
Humans
SARS-CoV-2
Treatment Outcome
Langue:Anglais
Identificateurs:urn:issn:1745-6215
info:doi/10.1186/s13063-022-06259-z
info:pii/10.1186/s13063-022-06259-z
info:pmid/35585600
PMC9116021